Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Gamida Cell and Be The Match BioTherapies® Announce Strategic Collaboration
Wednesday, January 23, 2019Gamida Cell Ltd a leading cellular and immune therapeutics company and Be The Match BioTherapies a subsidiary of the National Marrow Donor ProgramBe The Match offering integrated platforms and software to manage the collection and delivery of cellula...
Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize iARN Therapeutics in Israel
Tuesday, January 22, 2019Alnylam Pharmaceuticals Inc Leader of iARN Therapeutics and Medison Pharma Israels Leading Commercial Partner for Innovative Pharmaceuticals announced today an exclusive agreement to market ONPATTRO the first ever commercialized iARN therapeutic a...
Thyas Obtains Exclusive Rights to Manufacture Induced Pluripotent Stem Cells-Derived Killer T Cells for Autologous Immunotherapy
Monday, January 21, 2019Thyas Co Ltd Thyas signed a licensing agreement with iPS Academia Japan Inc iPSAJ a technology licensing organization of induced pluripotent stem iPS cell relatedpatents from Kyoto University Under the agreement Thyas obtains exclusive rights on pate...
Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene to Develop Immuno-oncology Therapies
Saturday, January 19, 2019Kyn Therapeutics a clinicalstage biotechnology company advancing research into new immunometabolic therapies for treating cancer today announced it has entered into a global strategic collaboration with Celgene Corporation The goal of the collaborati...
Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies
Saturday, January 19, 2019Obsidian Therapeutics a biotechnology company developing cell therapies with pharmacologic operating systems today announced a strategic collaboration with Celgene Corporation NASDAQ CELG for the discovery and development of novel regulated cell ther...
Ablexis Announces Expansion of Non-Exclusive Perpetual License Agreement with Eli Lilly and Company
Friday, January 18, 2019Ablexis LLC a biopharmaceutical company focused on licensing its AlivaMab Mouse platform technology for antibody drug discovery today announced the expansion of its existing nonexclusive perpetual license agreement with Eli Lilly and Company The expa...
AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals
Friday, January 18, 2019AMAG Pharmaceuticals Inc announced today that it has completed the previously announced acquisition of Perosphere Pharmaceuticals Inc a private biopharmaceutical company Through this acquisition AMAG adds ciraparantag to its development portfolio Cir...
Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field
Thursday, January 17, 2019Luye Pharma has announced it has entered an agreement with AstraZeneca China the terms of which grant AstraZeneca China exclusive rights to promote Luye Pharmas Xuezhikang Capsules in mainland China This is the first time that a multinational pharmac...
Phoenix Molecular Designs Announces Collaboration To Develop Diagnostic for Triple-Negative Breast Cancer
Thursday, January 17, 2019Phoenix Molecular Designs a privatelyheld biotechnology company designing precise cancer therapeutics by targeting essential kinases announced that it has entered into a collaboration with Roche to develop a diagnostic CDx in triplenegative breast ca...
Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics
Wednesday, January 16, 2019Bioharmony Therapeutics Inc a biopharmaceutical company focusing on the development of novel therapeutics for hard to treat bacterial infections announced today that it has entered into a Collaborative Research and Licensing Agreement with Boehringer...
